Skip to content
Inciteful Med

Causes & Subtypes of Gastroparesis

Last updated:

Gastroparesis is primarily caused by three factors: idiopathic triggers (often following a viral infection), diabetes (damaging the vagus nerve), and surgical injury. Medications like GLP-1 agonists (Ozempic) and opioids can also mimic or worsen the condition by slowing stomach emptying.

Key Takeaways

  • • Idiopathic gastroparesis is the most common subtype, often appearing suddenly after a viral infection.
  • • Diabetic gastroparesis is caused by vagus nerve damage from long-term high blood sugar.
  • • Post-surgical gastroparesis can result from accidental nerve injury during lung transplants or abdominal operations.
  • • GLP-1 medications like Ozempic and Wegovy can temporarily mimic or worsen gastroparesis by slowing digestion.
  • • Identifying the specific cause of gastroparesis is essential for predicting outcomes and choosing the right treatment.

Gastroparesis is not a single disease, but a symptom of many different underlying issues. Identifying your specific subtype or etiology (the cause) is a crucial first step, as it helps your medical team predict your outlook and choose the best management strategies [1][2].

The Big Three: Most Common Causes

Most cases of gastroparesis fall into one of these three categories:

  1. Idiopathic Gastroparesis (approx. 58–63%): This is the most common subtype [3][1]. “Idiopathic” means the exact cause is unknown. However, many patients in this group report that their symptoms started suddenly after a viral illness, suggesting a post-viral cause where the infection may have temporarily or permanently affected the stomach’s nerves [4]. These patients often report more abdominal pain and feeling full quickly [2].
  2. Diabetic Gastroparesis (approx. 23–24%): This occurs when long-term high blood sugar damages the vagus nerve [3][5]. It is more common in Type 1 than Type 2 diabetes and is often associated with other complications like retinopathy (eye issues) or neuropathy (numbness in hands/feet) [6]. Patients with this type often experience more severe nausea and vomiting [3][2].
  3. Post-Surgical Gastroparesis (approx. 11%): This is caused by accidental injury to the vagus nerve during an operation [3]. While it can happen with many abdominal surgeries, the highest risks are seen with lung transplants (up to 57–67%), esophagectomies, and pancreatic surgeries [7][8][9]. It can also occur after Nissen fundoplication (reflux surgery), though it is often temporary [10][11].

Medication-Induced Gastroparesis

Certain modern medications can slow your digestion so much that they mimic or cause gastroparesis.

  • GLP-1 Agonists: These medications (such as Ozempic, Wegovy, and Mounjaro) work partly by intentionally slowing down the stomach to help with weight loss and blood sugar [12][13]. For some, this slowing becomes severe [14].
  • Is it Reversible? In many cases, the delayed emptying caused by these drugs is reversible once the medication is stopped, though it may take several weeks for the effect to wear off [15][16].
  • Opioids: Narcotic pain medications are well-known to slow the entire digestive tract and can significantly worsen existing gastroparesis [4].

Rare & Atypical Causes

While less common, other conditions can lead to “stomach paralysis”:

  • Connective Tissue Diseases (approx. 5%): Conditions like Scleroderma or Lupus (SLE) can cause the stomach muscles to become stiff or scarred [3][17][4]. These patients often report significant bloating and abdominal distension [3].
  • Neurological Disorders: Parkinson’s Disease is a frequent cause, with some degree of slow emptying affecting up to 70–100% of patients [18][19]. In these cases, the issue is usually with the brain’s signals to the stomach rather than the stomach itself [20].
  • Paraneoplastic Syndrome: Very rarely, certain types of cancer can cause the immune system to attack the nerves in the digestive tract [4].

Frequently Asked Questions

What is the most common cause of gastroparesis?
Idiopathic gastroparesis is the most common form, accounting for about 60% of cases. "Idiopathic" means the exact cause is unknown, but many patients report symptoms starting suddenly after a viral illness, suggesting a post-viral link.
Can diabetes cause gastroparesis?
Yes, long-term high blood sugar can damage the vagus nerve, which controls stomach muscles. This type affects about 24% of patients and is more common in Type 1 diabetes than Type 2.
Do medications like Ozempic cause gastroparesis?
Certain medications, particularly GLP-1 agonists like Ozempic, Wegovy, and Mounjaro, work by slowing digestion. Opioid pain relievers are also known to significantly slow the digestive tract and worsen symptoms.
Is medication-induced gastroparesis reversible?
In many cases, yes. If gastroparesis symptoms are caused by a GLP-1 agonist or other medication, the delayed emptying is often reversible once the drug is stopped, though it may take several weeks to resolve.
Can surgery trigger gastroparesis?
Yes, surgery can cause gastroparesis if the vagus nerve is accidentally injured. High-risk procedures include lung transplants, esophagectomies, pancreatic surgeries, and sometimes anti-reflux surgeries like Nissen fundoplication.

Questions for Your Doctor

  • • Based on my history, do you suspect my gastroparesis is idiopathic, or is there a clear underlying cause like diabetes or prior surgery?
  • • Could any of my current medications, such as GLP-1 agonists or pain relievers, be contributing to my slow digestion?
  • • If my gastroparesis is related to my diabetes, how will managing my blood sugar levels affect my symptoms?
  • • I've had surgery in the past (e.g., gallbladder, reflux, or lung transplant); is it possible this caused damage to my vagus nerve?
  • • If my condition is 'idiopathic,' should we be looking for other rare causes like an autoimmune or connective tissue disease?

Questions for You

  • • Did my symptoms start suddenly after a bout of 'stomach flu' or another viral illness?
  • • Have I noticed a pattern where my symptoms improve or worsen based on changes in my medication or blood sugar?
  • • In addition to my stomach issues, do I have other symptoms like skin changes, joint pain, or tremors that might point to a connective tissue or neurological cause?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium.

    Sarosiek I, Van Natta M, Parkman HP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(3)):e452-e464 doi:10.1016/j.cgh.2021.05.063.

    PMID: 34089855
  2. 2

    Diabetic Gastroparesis and Nondiabetic Gastroparesis.

    Shen S, Xu J, Lamm V, et al.

    Gastrointestinal endoscopy clinics of North America 2019; (29(1)):15-25 doi:10.1016/j.giec.2018.08.002.

    PMID: 30396524
  3. 3

    Atypical Causes of Gastroparesis: Prevalence, Gastric Emptying, and Clinical Features.

    Szeto L, Yazdian A, Parkman HP

    Journal of clinical gastroenterology 2023; (57(9)):895-900 doi:10.1097/MCG.0000000000001786.

    PMID: 36730846
  4. 4

    Pharmacologic treatments for gastroparesis.

    Camilleri M, Jencks KJ

    Pharmacological reviews 2025; (77(2)):100019 doi:10.1016/j.pharmr.2024.100019.

    PMID: 40148033
  5. 5

    Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity.

    Nguyen L, Wilson LA, Miriel L, et al.

    Neurogastroenterology and motility 2020; (32(8)):e13810 doi:10.1111/nmo.13810.

    PMID: 32061038
  6. 6

    Key variables associated with gastroparesis in diabetes patients with gastroparesis-like symptoms.

    Bekkelund M, Steinsvik EK, Valeur J, et al.

    Scandinavian journal of gastroenterology 2025; (60(9)):865-873 doi:10.1080/00365521.2025.2531038.

    PMID: 40650418
  7. 7

    Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients.

    Hirji SA, Gulack BC, Englum BR, et al.

    Clinical transplantation 2017; (31(10)) doi:10.1111/ctr.13065.

    PMID: 28758244
  8. 8

    Considerations and Indications for Gastric Emptying Scintigraphy in Lung Transplant Patients.

    Sisti JD, Bolet SI, Amanullah A, et al.

    Asia Oceania journal of nuclear medicine & biology 2025; (13(1)):53-61 doi:10.22038/aojnmb.2024.80821.1572.

    PMID: 39744049
  9. 9

    Association of pylorus preservation with outcomes of pancreaticoduodenectomy across the United States.

    Mahrokhi S, Sakowitz S, Aguayo E, et al.

    Surgery open science 2025; (28()):36-42 doi:10.1016/j.sopen.2025.10.005.

    PMID: 41244994
  10. 10

    Transient delayed gastric emptying following laparoscopic Nissen fundoplication for gastroesophageal reflux disease.

    He S, Jia Y, Xu F, et al.

    Langenbeck's archives of surgery 2021; (406(5)):1397-1405 doi:10.1007/s00423-021-02156-2.

    PMID: 33825044
  11. 11

    Minimally invasive Roux-en-Y reconstruction as a salvage operation after failed nissen fundoplication.

    Landreneau JP, Strong AT, Kroh MD, et al.

    Surgical endoscopy 2020; (34(5)):2211-2218 doi:10.1007/s00464-019-07010-7.

    PMID: 31346753
  12. 12

    The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review.

    Liu Z, Yu S, Jin X, et al.

    Drug design, development and therapy 2025; (19()):10383-10409 doi:10.2147/DDDT.S559919.

    PMID: 41312047
  13. 13

    Gastrointestinal Motility Effects of GLP-1 Receptor Agonists.

    Bellavance D, Chua S, Mashimo H

    Current gastroenterology reports 2025; (27(1)):49 doi:10.1007/s11894-025-00995-3.

    PMID: 40622491
  14. 14

    Gastrointestinal and Hepatobiliary Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes.

    Niu C, Sun K, Zhang J, et al.

    The American journal of gastroenterology 2025; doi:10.14309/ajg.0000000000003760.

    PMID: 40900093
  15. 15

    Efficacy and safety of semaglutide for weight management: evidence from the STEP program.

    Amaro A, Sugimoto D, Wharton S

    Postgraduate medicine 2022; (134(sup1)):5-17 doi:10.1080/00325481.2022.2147326.

    PMID: 36691309
  16. 16

    Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report.

    Parker AE

    Menopause (New York, N.Y.) 2025; doi:10.1097/GME.0000000000002621.

    PMID: 40729307
  17. 17

    Gastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors.

    Nassar Y, Richter S

    Gastroenterology research 2018; (11(5)):340-345 doi:10.14740/gr1060w.

    PMID: 30344804
  18. 18

    Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.

    Yan Y, Shimoga D, Sharma A

    Current gastroenterology reports 2023; (25(5)):106-113 doi:10.1007/s11894-023-00868-7.

    PMID: 37067721
  19. 19

    Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.

    Pellegrini C, Antonioli L, Colucci R, et al.

    Parkinsonism & related disorders 2015; (21(12)):1407-14.

    PMID: 26499757
  20. 20

    Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells.

    Heimrich KG, Jacob VYP, Schaller D, et al.

    NPJ Parkinson's disease 2019; (5()):15 doi:10.1038/s41531-019-0087-3.

    PMID: 31372495

This guide explains the causes and subtypes of gastroparesis for educational purposes only. Always consult your gastroenterologist for proper diagnosis and management of your specific condition.

Stay up to date

Get notified when new research about Gastroparesis is published.

No spam. Unsubscribe anytime.